- Home
- ASBP vs BNGO Comparison
ASBP vs BNGO Comparison
Compare ASBP & BNGO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ASBP
- BNGO
- Stock Information
- Founded
- ASBP 2021
- BNGO 2003
- Country
- ASBP United States
- BNGO United States
- Employees
- ASBP N/A
- BNGO N/A
- Industry
- ASBP Biotechnology: Pharmaceutical Preparations
- BNGO Biotechnology: Laboratory Analytical Instruments
- Sector
- ASBP Health Care
- BNGO Industrials
- Exchange
- ASBP Nasdaq
- BNGO Nasdaq
- Market Cap
- ASBP 26.6M
- BNGO 24.3M
- IPO Year
- ASBP N/A
- BNGO 2018
- Fundamental
- Price
- ASBP $0.41
- BNGO $2.77
- Analyst Decision
- ASBP
- BNGO Buy
- Analyst Count
- ASBP 0
- BNGO 4
- Target Price
- ASBP N/A
- BNGO $7.67
- AVG Volume (30 Days)
- ASBP 28.5M
- BNGO 373.5K
- Earning Date
- ASBP 08-13-2025
- BNGO 11-12-2025
- Dividend Yield
- ASBP N/A
- BNGO N/A
- EPS Growth
- ASBP N/A
- BNGO N/A
- EPS
- ASBP N/A
- BNGO N/A
- Revenue
- ASBP N/A
- BNGO $27,426,000.00
- Revenue This Year
- ASBP N/A
- BNGO N/A
- Revenue Next Year
- ASBP N/A
- BNGO $20.81
- P/E Ratio
- ASBP N/A
- BNGO N/A
- Revenue Growth
- ASBP N/A
- BNGO N/A
- 52 Week Low
- ASBP $0.22
- BNGO $2.68
- 52 Week High
- ASBP $15.80
- BNGO $30.52
- Technical
- Relative Strength Index (RSI)
- ASBP 41.86
- BNGO 37.38
- Support Level
- ASBP $0.37
- BNGO $3.55
- Resistance Level
- ASBP $0.47
- BNGO $5.50
- Average True Range (ATR)
- ASBP 0.05
- BNGO 0.47
- MACD
- ASBP -0.02
- BNGO -0.09
- Stochastic Oscillator
- ASBP 18.62
- BNGO 0.00
About ASBP Aspire Biopharma Holdings Inc. Common Stock
Aspire Biopharma Holdings Inc developing next-generation absorption of medicine that will have an impact on the opioid crisis. The group engaged in the business of developing and marketing disruptive technology for novel delivery mechanisms for do-no-harm drugs. Its nanotechnology drug formulation directly targets pain and inflammation bypassing the gastrointestinal tracts.
About BNGO Bionano Genomics Inc.
Bionano Genomics Inc is a life sciences instrumentation company in the genome analysis space. It is engaged in the development and marketing of the Saphyr system, a platform for ultra-sensitive and ultra-specific structural variation detection that enables researchers and clinicians to accelerate the search for new diagnostics and therapeutic targets and to streamline the study of changes in chromosomes. Geographically, it operates in Americas, EMEA and Asia Pacific; majority revenue being generated from Americas. They generate product revenue from sales of its OGM and Ionic Purification systems and consumables, which includes its instruments, and their VIA software.